Skip to Content Skip to Search

Supply updates

We commit to ensuring the quality, safety and reliable supply of our products. If the supply of our medicines or vaccines is disrupted in Australia we will publish details here.

We are actively managing our global supply chains to minimise potential disruption, and we are monitoring the situation closely. We will put the needs of patients first at all times.

At present, with the exception of specific supply disruptions as outlined below, we have adequate stock in place in Australia.

 

We are currently experiencing a supply shortage for Varilrix (varicella vaccine, live, attenuated). We expect this shortage to continue until early August 2022. An alternative vaccine remains available in Australia, and therefore, we do not anticipate significant impacts for patients. For further questions, please contact your healthcare provider.

 

Please visit the TGA website for ongoing updates to supply.

For more information on GSK's medicines or vaccines, please contact GSK medical information on 1800 033 109.